Australian Bill Brings Further Price Cuts But Promise Of More New Drug Listings
Executive Summary
A new bill just approved in Australia will introduce further price cuts in order to reap savings on the pharmaceutical bill, which will partly be used to fund the reimbursement listing of new drugs. The pharmaceutical industry will also benefit from a more predictable pricing environment, at least until 2022.